HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Alan S Coates Selected Research

letrozole (Femara)

12/2015ESR1 and ESR2 polymorphisms in the BIG 1-98 trial comparing adjuvant letrozole versus tamoxifen or their sequence for early breast cancer.
9/2015Relative Effectiveness of Letrozole Compared With Tamoxifen for Patients With Lobular Carcinoma in the BIG 1-98 Trial.
6/2015CYP19A1 polymorphisms and clinical outcomes in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial.
11/2012Obesity and risk of recurrence or death after adjuvant endocrine therapy with letrozole or tamoxifen in the breast international group 1-98 trial.
3/2012CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: the breast international group 1-98 trial.
11/2011Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up.
3/2011Analyses adjusting for selective crossover show improved overall survival with adjuvant letrozole compared with tamoxifen in the BIG 1-98 study.
2/2011Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trial.
10/2010Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen for breast cancer in the BIG 1-98 randomized trial.
8/2009Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Alan S Coates Research Topics

Disease

55Breast Neoplasms (Breast Cancer)
12/2015 - 04/2003
28Neoplasms (Cancer)
12/2015 - 10/2002
3Carcinoma (Carcinomatosis)
09/2009 - 03/2003
3Hypercholesterolemia
12/2007 - 12/2005
2Ductal Carcinoma
09/2015 - 09/2009
2Arthralgia (Joint Pain)
07/2015 - 02/2007
2Bone Fractures (Bone Fracture)
04/2008 - 02/2007
2Hot Flashes
02/2007 - 01/2007
2Hemorrhage
02/2007 - 12/2005
2Amenorrhea
01/2007 - 03/2006
2Endometrial Neoplasms (Endometrial Cancer)
12/2005 - 12/2004
1Lobular Carcinoma
09/2015
1Osteoporosis
04/2014
1Obesity
11/2012
1Infection
12/2011
1Stomatitis
12/2011
1Neutropenia
12/2011
1Anemia
01/2008
1Hypertension (High Blood Pressure)
12/2007
1Neoplasm Metastasis (Metastasis)
05/2007
1Heart Failure
02/2007
1Ischemia
02/2007
1Cataract (Cataracts)
02/2006
1Neuritis (Polyneuritis)
02/2006
1Thromboembolism
12/2005
1Noninfiltrating Intraductal Carcinoma (DCIS)
09/2003
1Vaccinia
10/2002
1Melanoma (Melanoma, Malignant)
10/2002

Drug/Important Bio-Agent (IBA)

30TamoxifenFDA LinkGeneric
12/2015 - 09/2003
21Estrogens (Estrogen)FDA Link
12/2015 - 03/2003
17letrozole (Femara)FDA LinkGeneric
12/2015 - 12/2005
14HormonesIBA
12/2015 - 12/2005
10Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2013 - 04/2003
8Fluorouracil (Carac)FDA LinkGeneric
01/2013 - 04/2003
8Methotrexate (Mexate)FDA LinkGeneric
01/2013 - 04/2003
5exemestane (Aromasin)FDA Link
07/2015 - 03/2004
5Progesterone Receptors (Progesterone Receptor)IBA
06/2010 - 03/2003
4DNA (Deoxyribonucleic Acid)IBA
12/2015 - 06/2010
4Aromatase (CYP19)IBA
07/2014 - 12/2005
3Aromatase InhibitorsIBA
12/2013 - 12/2007
3glucuronyl glucosamine glycan sulfate (Vessel)IBA
06/2008 - 10/2005
3Goserelin (Zoladex)FDA Link
03/2008 - 12/2003
2ProgesteroneFDA LinkGeneric
04/2013 - 09/2007
2Phenobarbital (Luminal)FDA Link
04/2012 - 12/2010
2Epirubicin (Ellence)FDA LinkGeneric
01/2009 - 01/2006
2Toremifene (Fareston)FDA Link
02/2006 - 12/2004
1Estrogen Receptor alphaIBA
12/2015
1OsteocalcinIBA
04/2014
1collagen type I trimeric cross-linked peptideIBA
04/2014
1Alkaline PhosphataseIBA
04/2014
1Carbon MonoxideIBA
04/2013
11-dodecylpyridoxal (PLD)IBA
04/2013
1pegylated liposomal doxorubicinIBA
04/2013
1Prednisone (Sone)FDA LinkGeneric
01/2013
1Mitoxantrone (Novantrone)FDA LinkGeneric
01/2013
1Cytochrome P-450 CYP2D6 (CYP2D6)IBA
03/2012
1P-2 (P 2)IBA
12/2011
1capecitabine (Xeloda)FDA Link
12/2011
1Androgen Receptors (Androgen Receptor)IBA
12/2010
1Epidermal Growth Factor Receptor (EGF Receptor)IBA
06/2010
1Alkylating AgentsIBA
06/2010
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2009
1Estrogen ReceptorsIBA
12/2008
1trastuzumab (Herceptin)FDA Link
06/2008
1Ki-67 Antigen (Ki 67 Antigen)IBA
02/2008
1taxaneIBA
01/2008
1Hemoglobins (Hemoglobin)IBA
01/2008
1A-factor (Streptomyces)IBA
11/2006
1Retinaldehyde (Retinal)IBA
02/2006
1Filgrastim (Neupogen)FDA Link
01/2006
1Gonadotropin-Releasing Hormone (GnRH)FDA Link
12/2003
1Cyclin-Dependent Kinase Inhibitor p27IBA
04/2003
1Thymidylate SynthaseIBA
04/2003
1Biological Markers (Surrogate Marker)IBA
03/2003

Therapy/Procedure

26Drug Therapy (Chemotherapy)
07/2015 - 04/2003
14Adjuvant Chemotherapy
02/2014 - 04/2003
2Segmental Mastectomy (Lumpectomy)
02/2014 - 06/2008
2Mastectomy (Mammectomy)
02/2014 - 06/2008
1Radiotherapy
05/2007
1Immunotherapy
10/2002